Director Share Dealings - Xvivo Perfusion AB (XVIVO)

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

≈ Figures for the value of trade may not add up due to rounding.

Recent deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
21 July 2026	Emil Anders BillbäckIndependent Director	Buy Regular purchase transaction	1,643	235.80 SEK	387,419.40 SEK	4,104
21 July 2026	Emil Anders BillbäckIndependent Director	Buy Regular purchase transaction	2,007	235.80 SEK	473,250.60 SEK	2,461
20 March 2026	Kristoffer NordströmCFO	Buy Regular purchase transaction	300	181.00 SEK	54,300.00 SEK	4,000
3 December 2025	Kristoffer NordströmCFO	Buy Regular purchase transaction	250	169.80 SEK	42,450.00 SEK	3,700
3 December 2025	Kristoffer NordströmCFO	Buy Regular purchase transaction	250	169.70 SEK	42,425.00 SEK	3,450
18 November 2025	Lena HagmanCOO	Buy Regular purchase transaction	1,500	161.00 SEK	241,500.00 SEK	5,000

End of results. Director deals are only available for the last 12 months.

5 most significant deals

Date	Name and position (if held)	Deal type	Number of shares dealt	Price per share	Value of trade ≈	Shares remaining
21 July 2026	Emil Anders BillbäckIndependent Director	Buy Regular purchase transaction	2,007	235.80 SEK	473,250.60 SEK	2,461
21 July 2026	Emil Anders BillbäckIndependent Director	Buy Regular purchase transaction	1,643	235.80 SEK	387,419.40 SEK	4,104
18 November 2025	Lena HagmanCOO	Buy Regular purchase transaction	1,500	161.00 SEK	241,500.00 SEK	5,000
20 March 2026	Kristoffer NordströmCFO	Buy Regular purchase transaction	300	181.00 SEK	54,300.00 SEK	4,000
3 December 2025	Kristoffer NordströmCFO	Buy Regular purchase transaction	250	169.80 SEK	42,450.00 SEK	3,700

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.